Citation: Jh. Friedman et Br. Ott, SHOULD RISPERIDONE BE USED IN PARKINSONS-DISEASE, The Journal of neuropsychiatry and clinical neurosciences, 10(4), 1998, pp. 473-474
Authors:
TROSCH RM
FRIEDMAN JH
LANNON MC
PAHWA R
SMITH D
SEEBERGER LC
OBRIEN CF
LEWITT PA
KOLLER WC
Citation: Rm. Trosch et al., CLOZAPINE USE IN PARKINSONS-DISEASE - A RETROSPECTIVE ANALYSIS OF A LARGE MULTICENTERED CLINICAL-EXPERIENCE, Movement disorders, 13(3), 1998, pp. 377-382
Authors:
SHOULSON I
OAKES D
FAHN S
LANG A
LANGSTON JW
LEWITT P
OLANOW CW
PENNEY JB
TANNER C
KIEBURTZ K
KOLLER W
RODNITZKY R
FINK JS
GROWDON JH
PAULSON G
KURLAN R
FRIEDMAN JH
GANCHER S
NUTT J
RAJPUT AH
BENNETT JB
WOOTEN GF
GOETZ C
SHANNON K
SUCHOWERSKY O
BRIN MF
BRESSMAN SB
WEINER WJ
SANCHEZRAMOS J
JANKOVIC J
TETRUD J
GRIMES JD
PFEIFFER R
SHULTS C
THAL L
GAUTHIER S
GOLBE LI
PERLMUTTER JS
MOSES H
REICH SG
HURTIG HI
STERN M
BARTER R
VETEREOVERFIELD B
GAUGER L
MALAPIRA T
DOBSON J
ATAMIAN S
TENNIS M
COHEN JB
DESCLOS G
HOFFMAN E
GRAEFE K
BURKE C
MARCUS A
DENIO L
HUBER S
WOIKE T
ZOOG K
MENDELL R
DUDTE K
BEHR J
GARDINER IF
LANNON M
CARTER J
NORTHRUP S
KANIGAN B
TURK M
LANDOW E
SCHLICK P
MISTURA K
CARROLL VS
THELEN JA
DEMONG C
WINFIELD L
MOSKOWITZ C
INGENITO A
SHELDON C
CORNELIUS L
HEIBERG D
DUNNE C
BRADY J
KIERANS C
BELLESCANTLEBURY L
DUFF J
WEBER H
SAVOINI D
LEWIS P
KUTNER SJ
GRAY P
GLAESKE C
HOFMAN R
PAY M
SALMON D
MCFAUL F
AMYOT D
BERGEN M
MCGEEMINNICH L
ODONNELL P
FERRISE S
SHALLOW K
Citation: I. Shoulson et al., MORTALITY IN DATATOP - A MULTICENTER TRIAL IN EARLY PARKINSONS-DISEASE, Annals of neurology, 43(3), 1998, pp. 318-325
Citation: Jh. Friedman et al., SUBSTITUTING CLOZAPINE FOR OLANZAPINE IN PSYCHIATRICALLY STABLE PARKINSONS-DISEASE PATIENTS - RESULTS OF AN OPEN-LABEL PILOT-STUDY, Clinical neuropharmacology, 21(5), 1998, pp. 285-288
Authors:
GROWDON JH
KIEBURTZ K
MCDERMOTT MP
PANISSET M
FRIEDMAN JH
Citation: Jh. Growdon et al., LEVODOPA IMPROVES MOTOR FUNCTION WITHOUT IMPAIRING COGNITION IN MILD NONDEMENTED PARKINSONS-DISEASE PATIENTS, Neurology, 50(5), 1998, pp. 1327-1331
Authors:
FRIEDMAN JH
LANNON MC
FACTOR S
COMELLA C
PARSA M
PFEIFFER R
RICHARDS I
KURLAN R
Citation: Jh. Friedman et al., LOW-DOSE CLOZAPINE FOR THE TREATMENT OF DRUG-INDUCED PSYCHOSIS (DIP) IN IDIOPATHIC PARKINSONS-DISEASE (PD) - RESULTS OF THE DOUBLE-BLIND, PLACEBO-CONTROLLED PSYCLOPS TRIAL, Neurology, 50(4), 1998, pp. 7002-7002
Citation: Sa. Factor et Jh. Friedman, THE EMERGING ROLE OF CLOZAPINE IN THE TREATMENT OF MOVEMENT-DISORDERS, Movement disorders, 12(4), 1997, pp. 483-496
Citation: Wl. Griffin et al., STATISTICAL TECHNIQUES FOR THE CLASSIFICATION OF CHROMITES IN DIAMONDEXPLORATION SAMPLES, Journal of geochemical exploration, 59(3), 1997, pp. 233-249
Authors:
MALASPINA D
SUSSER E
BETNE P
FRIEDMAN JH
FARAONE S
TSUANG M
CLONINGER R
KAUFMANN C
Citation: D. Malaspina et al., PSYCHOSIS AND TRAUMATIC BRAIN INJURY IN MULTIPLEX SCHIZOPHRENIA FAMILIES, American journal of medical genetics, 74(6), 1997, pp. 562-563
Citation: L. Breiman et Jh. Friedman, PREDICTING MULTIVARIATE RESPONSES IN MULTIPLE LINEAR-REGRESSION, Journal of the Royal Statistical Society. Series B: Methodological, 59(1), 1997, pp. 3-37
Citation: Jh. Friedman et al., A 64-YEAR-OLD MAN WITH PROGRESSIVE DEMENTIA, SEIZURES, AND UNSTABLE GAIT - PROGRESSIVE SUPRANUCLEAR PALSY, The New England journal of medicine, 337(8), 1997, pp. 549-556
Citation: Km. Shannon et al., EFFICACY OF PRAMIPEXOLE, A NOVEL DOPAMINE AGONIST, AS MONOTHERAPY IN MILD-TO-MODERATE PARKINSONS-DISEASE, Neurology, 49(3), 1997, pp. 724-728
Authors:
RICHARD IH
KURLAN R
TANNER C
FACTOR S
HUBBLE J
SUCHOWERSKY O
WATERS C
GOETZ C
JUNCOS JL
STERN M
HARRISON MB
SETHI KD
STANDAERT D
TROSCH R
REICH S
KIEBURTZ K
FEIGIN A
MARSHALL FJ
GAUTHIER S
PANISSET M
LEW ME
FRIEDMAN JH
PAULSON G
RODNITZKY RL
HAUSER R
KURTH M
HURTIG H
THAL L
ELMER LW
PERLMUTTER JS
GOLBE LI
COMELLA C
LANG A
MARK MH
SINGER C
SHOULSON I
WEINER WJ
PFEIFFER R
MAREK KL
NUTT J
WOOTEN GF
JANKOVIC J
LEWITT P
HOEHN M
BENNETT J
PARSA M
KOLLER W
Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077
Citation: Jh. Friedman et al., MIANSERIN TREATMENT OF PATIENTS WITH PSYCHOSIS INDUCED BY ANTIPARKINSONIAN DRUGS - COMMENT, European archives of psychiatry and clinical neuroscience, 246(2), 1996, pp. 106-106
Citation: Jh. Friedman, WALKING-INDUCED PARKINSONISM DUE TO PRESUMED IDIOPATHIC NORMAL-PRESSURE HYDROCEPHALUS, Movement disorders, 11(1), 1996, pp. 99-101
Authors:
SHOULSON I
FAHN S
OAKES D
LANG A
LANGSTON JW
LEWITT P
OLANOW CW
PENNEY JB
TANNER C
KIEBURTZ K
KOLLER W
RODNITZKY R
FINK JS
GROWDON JH
PAULSON G
KURLAN R
FRIEDMAN JH
GANCHER S
NUTT J
RAJPUT AH
BENNETT JB
WOOTEN GF
GOETZ C
SHANNON K
SUCHOWERSKY O
BRIN MF
BRESSMAN SB
WEINER WJ
SANCHEZRAMOS J
JANKOVIC J
HOEHN M
TETRUD J
GRIMES JD
PFEIFFER R
SHULTS C
THAL L
GAUTHIER S
GOLBE LI
PERLMUTTER JS
MOSES H
REICH SG
HURTIG HI
STERN M
BARTER R
VETEREOVERFIELD B
GAUGER L
MALAPIRA T
DOBSON J
ATAMIAN S
TENNIS M
COHEN JB
DESCLOS G
HOFFMAN E
DENIO L
HUBER S
WOIKE T
ZOOG K
MENDELL R
DUDTE K
BEHR J
GARDINER IF
LANNON M
CARTER J
NORTHRUP S
KANIGAN B
TURK M
LANDOW E
SCHLICK P
MISTURA K
CARROLL VS
THELEN JA
DEMONG C
WINFIELD L
MOSKOWITZ C
INGENITO A
SHELDON C
CORNELIUS L
HEIBERG D
DUNNE C
BRADY J
KIERANS C
BELLESCANTLEBURY L
DUFF J
WEBER H
SAVOINI D
LEWIS P
KUTNER SJ
GRAY P
GLAESKE C
HOFMAN R
PAY MM
SALMON D
MCFAUL F
AMYOT D
BERGEN M
MCGEEMINNICH L
ODONNELL P
FERRISE S
SHALLOW K
BAKER D
CASACELI C
EBERLY S
MCDERMOTT M
NOBEL R
ORME C
PELUSIO RM
PLUMB S
RUDOLPH A
RANDOLPH H
SOTACK J
WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36